MarketLens
Sign Up

Has COMPASS Pathways Finally Turned the Corner

8 months ago
SHARE THIS ON:

Has COMPASS Pathways Finally Turned the Corner

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•3 weeks ago

Compass Pathways PLC Sponsored ADR (NASDAQ:CMPS) Stock Has Consensus Target Price of $23.36 According to Brokerages

Compass Pathways PLC Sponsored ADR (NASDAQ:CMPS) received a "Moderate Buy" consensus from 17 brokerages, with 14 buy, 1 hold, and 1 sell rating, and an average target price of $23.36.
Stock News•4 weeks ago

Compass Pathways Eyes 2027 COMP360 Launch as FDA Review Advances

Compass Pathways expects to complete its COMP360 NDA submission in Q4 and launch in the U.S. in H1 2027, executives said at the Morgan Stanley healthcare conference. The psilocybin treatment targets t...
Stock News•3 months ago

This Psychedelic Pharma Stock Is Soaring 50% on Report of Eli Lilly Takeover Talks

Psychedelic pharma stock soared ~50% after a report that Eli Lilly is in takeover talks at a premium, per the report.

Breaking News

View All →

Top Headlines

View More →
Stock News•1 hour ago

Farkas Says Starlink Slowdown Helped the Russians

Stock News•1 hour ago

Amazon (AMZN) Suffers a Larger Drop Than the General Market: Key Insights

Stock News•1 hour ago

Here's Why Dell Technologies (DELL) Fell More Than Broader Market

Stock News•1 hour ago

Microsoft (MSFT) Falls More Steeply Than Broader Market: What Investors Need to Know

Stock News•1 hour ago

Elon Musk's Tesla eyes transportation ‘domination' as Cybercab expansion heats up competition with Waymo